Log in
Enquire now
Voyager Therapeutics

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company founded in 2014 that is headquartered in Cambridge, Massachusetts developing gene therapies to treat neurological disorders.

OverviewStructured DataIssuesContributors

Contents

voyagertherapeutics.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
‌
Neurodegenerative Disease
0
Therapeutics
Therapeutics
Gene therapy
Gene therapy
Neuroscience
Neuroscience
Consumer biotechnology
Consumer biotechnology
Biomedical engineering
Biomedical engineering
...
Location
United States
United States
Cambridge, Massachusetts
Cambridge, Massachusetts
0
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire
B2X
B2B
B2B
CEO
‌
Al Sandrock
0
‌
Michael Higgins
0
Founder
‌
Mark Kay
0
‌
Krystof Bankiewicz
‌
Guangping Gao
0
‌
Phillip D. Zamore
0
AngelList URL
angel.co/voyager-therapeutics
Pitchbook URL
pitchbook.com/profiles.../61454-17
Legal Name
Voyager Therapeutics, Inc.0
Legal classification
Corporation
Corporation
Date Incorporated
2014
Number of Employees (Ranges)
51 – 2000
Phone Number
+185725953400
Number of Employees
101
Full Address
64 Sidney St., Cambridge, MA 02139, USA0
CIK Number
1,640,2660
Place of Incorporation
Delaware
Delaware
0
Investors
Brookside Capital
Brookside Capital
Third Rock Ventures
Third Rock Ventures
Founded Date
2014
0
Total Funding Amount (USD)
135,000,000
Latest Funding Round Date
April 2015
Competitors
Code Biotherapeutics
Code Biotherapeutics
Intellia Therapeutics
Intellia Therapeutics
Stock Symbol
VYGR0
Exchange
Nasdaq
Nasdaq
Board of Directors
‌
Jim Geraghty
0
‌
Steven Hyman
0
Steven Paul
Steven Paul
0
‌
Al Sandrock
0
‌
Michael Higgins
0
Former CEO
‌
Andre Turenne
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
10
Wellfound ID
voyager-therapeutics
Country
United States
United States
0

Other attributes

Company Operating Status
Active
SIC Code
2,8360
Ticker Symbol
VYGR0
Wikidata ID
Q106411854

Voyager Therapeutics is a biotechnology company that is headquartered in Cambridge, Massachusetts that was founded by Guangping Gao, Krystof Bankiewicz, Mark Kay, and Phillip D. Zamore in 2014.

The company is developing novel gene therapies using the adeno-associated virus (AAV) for the treatment of neurological disorders such as Parkinson's disease, amyotrophic lateral sclerosis (ALS), Friedreich's ataxia, Huntington's disease, and Alzheimer's disease.

Funding
Corporate round

On February 11, 2015 Voyager Therapeutics announced they raised $30 million in their corporate funding round from Genzyme.

Series A

On February 12, 2014 Voyager Therapeutics closed their series A funding round with $45 million in funding from Third Rock Ventures.

Series B

On April 13, 2015 Voyager Therapeutics closed their series B funding round with $60 million in funding from Wellington Management, Partner Fund Management, Fidelity Management and Research Company, Casdin Capital, and Brookside Capital.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Neurocrine Biosciences and Voyager Therapeutics Form Strategic Development and Commercialization Collaboration for Parkinson's Disease and Friedreich's Ataxia

Voyager Therapeutics, Inc.

https://www.globenewswire.com/news-release/2019/01/29/1706690/0/en/Neurocrine-Biosciences-and-Voyager-Therapeutics-Form-Strategic-Development-and-Commercialization-Collaboration-for-Parkinson-s-Disease-and-Friedreich-s-Ataxia.html

Web

Voyager Therapeutics Receives FDA Guidance on Development Path for VY-AADC for Parkinson's Disease and Provides Clinical Update

Global News Wire

https://globenewswire.com/news-release/2018/07/17/1538187/0/en/Voyager-Therapeutics-Receives-FDA-Guidance-on-Development-Path-for-VY-AADC-for-Parkinson-s-Disease-and-Provides-Clinical-Update.html

Web

References

Find more companies like Voyager Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.